These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27463845)

  • 1. Drug-Target Networks.
    Vogt I; Mestres J
    Mol Inform; 2010 Jan; 29(1-2):10-4. PubMed ID: 27463845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational tools for polypharmacology and repurposing.
    Achenbach J; Tiikkainen P; Franke L; Proschak E
    Future Med Chem; 2011 Jun; 3(8):961-8. PubMed ID: 21707399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building a drug-target network and its applications.
    Lee S; Park K; Kim D
    Expert Opin Drug Discov; 2009 Nov; 4(11):1177-89. PubMed ID: 23480435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple mathematical approach to the analysis of polypharmacology and polyspecificity data.
    Maggiora G; Gokhale V
    F1000Res; 2017; 6():. PubMed ID: 28690829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Receptorome Screening of Antipsychotic Drugs.
    Vidal D; Mestres J
    Mol Inform; 2010 Jul; 29(6-7):543-51. PubMed ID: 27463332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products.
    Kibble M; Saarinen N; Tang J; Wennerberg K; Mäkelä S; Aittokallio T
    Nat Prod Rep; 2015 Aug; 32(8):1249-66. PubMed ID: 26030402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network approaches to drug discovery.
    Chandra N; Padiadpu J
    Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DrugViz: a Cytoscape plugin for visualizing and analyzing small molecule drugs in biological networks.
    Xiong B; Liu K; Wu J; Burk DL; Jiang H; Shen J
    Bioinformatics; 2008 Sep; 24(18):2117-8. PubMed ID: 18658180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphs and networks in chemical and biological informatics: past, present and future.
    Sukumar N; Krein MP
    Future Med Chem; 2012 Oct; 4(16):2039-47. PubMed ID: 23157237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferring Chemogenomic Features from Drug-Target Interaction Networks.
    Yamanishi Y
    Mol Inform; 2013 Dec; 32(11-12):991-9. PubMed ID: 27481144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery.
    Medina-Franco JL; Méndez-Lucio O; Martinez-Mayorga K
    Adv Protein Chem Struct Biol; 2014; 96():1-37. PubMed ID: 25443953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missing Value Estimation for Compound-Target Activity Data.
    Tanrikulu Y; Kondru R; Schneider G; So WV; Bitter HM
    Mol Inform; 2010 Oct; 29(10):678-84. PubMed ID: 27464011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
    Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
    J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemogenomics knowledgebased polypharmacology analyses of drug abuse related G-protein coupled receptors and their ligands.
    Xie XQ; Wang L; Liu H; Ouyang Q; Fang C; Su W
    Front Pharmacol; 2014; 5():3. PubMed ID: 24567719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.